Milestone Pharmaceuticals Inc. ( MIST) - Key Metrics
MIST Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.21 | $0 | $0 |
| 2026Q1 | $0 | -$0.20 | -$0.12 | -$0.12 |
| 2025Q4 | $0.02 | -$0.21 | -$0.15 | -$0.15 |
| 2025Q3 | $0 | -$0.18 | -$0.15 | -$0.15 |
| 2025Q2 | $0 | -$0.20 | -$0.19 | -$0.19 |
MIST Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -1.60 |
| 2026Q1 | 0% | -1.49 |
| 2025Q4 | 0% | -3.16 |
| 2025Q3 | 0% | -4.17 |
| 2025Q2 | 0% | -2.43 |
MIST
Price: $1.10
52 week price:
Earnings Per Share: -0.65 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: Canada
Volume: 563278
Market Capitalization: 136.9 million